Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis.

Ugo CucinottaValeria DipasqualeStefano CostaSalvatore PellegrinoVincenzo RamistellaClaudio Romano

Published in: Journal of clinical pharmacy and therapeutics (2021)

To our knowledge, this is the first case report of VDZ-associated pulmonary manifestations in paediatrics. A direct, pro-inflammatory effect of VDZ has been hypothesized, but further studies are warranted.

Keyphrases

ulcerative colitis
case report
pulmonary hypertension
healthcare
young adults